Pharma Equity Group AS (OCSE:PEG) EV-to-EBIT : -6.03 (As of May. 29, 2025)

Pharma Equity Group AS EV-to-EBIT Chart

Pharma Equity Group AS Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
EV-to-EBIT		Get a 7-Day Free Trial					-1.23	6.57	-3.52	-18.62	-11.41

Pharma Equity Group AS Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EV-to-EBIT	Get a 7-Day Free Trial															-18.62	-14.15	-11.82	-9.42	-11.41

Competitive Comparison of Pharma Equity Group AS's EV-to-EBIT

For the Biotechnology subindustry, Pharma Equity Group AS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Equity Group AS's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Equity Group AS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Pharma Equity Group AS's EV-to-EBIT falls into.

Pharma Equity Group AS EV-to-EBIT Calculation

Pharma Equity Group AS's EV-to-EBIT for today is calculated as:

Pharma Equity Group AS's current Enterprise Value is kr128.33 Mil.
Pharma Equity Group AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-21.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Equity Group AS  (OCSE:PEG) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Pharma Equity Group AS's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

Pharma Equity Group AS's Enterprise Value for the quarter that ended in Dec. 2024 was kr242.73 Mil.
Pharma Equity Group AS's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-21.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Equity Group AS EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group AS's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group AS Business Description